Longitudinal Study of Behavioral Changes, Economic and Sociological After CAncer (ELCCA-II)

Institut Cancerologie de l'Ouest

Status: Completed

Conditions: Breast Cancer; Melanoma

Treatments: Other: quality of life assessment

Study type: Interventional

Funder types: Other

Identifiers

NCT02893774

2014-A01675-42 (Other Identifier)

ICO-N-2014-10

Details and patient eligibility

About

Generally, French studies concerned with the quality of life of cancer patients focus on the period of treatment (up to 2 years post diagnosis). However, studies about quality of life "after" cancer are relatively rare (= long-term quality of life, or from 5 years post diagnosis). These studies mainly concern the most common cancers (breast and prostate).

Or changes in quality of life after treatment could be different depending on the type of cancer. In addition, there is a significant influence of sociodemographic variables on the quality of life in remission.

Similarly using remote diagnostics, quality of life questionnaires related to health, must be reassessed because too often developed for situations in process.

Based on these findings, "ELCCA II" study proposes to study for five years, the evolution of the impacts of two types of cancer (breast and melanoma) on quality of life (overall and related to the subjective health), socioeconomic status, and behavioral and emotional dimensions (post-traumatic development, coping, anxiety-depression) of those treated.

Enrollment: 314 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosis of cancer (breast or melanoma) since less than 1 month
• no metastasis
• Inform Consent Form signed

Exclusion criteria

• severe psychiatric disorder (depression, psychosis, etc.)
• addictive pathology
• longtime antidepressant treatment (> 3 months)
• Patient pregnant or breastfeeding

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

314 participants in 1 patient group

cancer quality of life

Experimental group

Description:

All patients with breath cancer or melanoma will have quality of life assessment 1, 6, 12, 24, 48 and 60 months after the initial cancer diagnosis

Treatment:

Other: quality of life assessment